← Back to Patent Explorer
US4785012A Expired / Lapsed US ⏱️ 0.0 years remaining

Oxazole anthelmintic agents of marine origin

Assignee: University of California
•
Filing: 1987-04-09
•
Granted: 1988-11-15
•
Expires: 2007-04-09
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract New oxazole derivatives of formula 1 and their pharmacetically acceptable salts have anthelmintic activity: <IMAGE> (1) where R is H, OH, or acyloxy of 8 to 22 carbon atoms; R1, R2, R3, and R4 are each independently H or acyl of 1 to 6 carbon atoms.

Inventors

  • 👤 Philip Crews
  • 👤 Thomas R. Matthews
  • 👤 Emilio Q. Cabana
  • 👤 Madeline Adamczeski

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-31 13:52
CPC Classifications
C; C07; C07D; C07D263/00; C07D263/02; C07D263/30; C07D263/32

Claims Analysis

Total Claims: 23
Claim 1
Independent Claim 54 words
A compund in substantially pure form of formula 1: ##STR7## where R is H, OH, or saturated acyloxy of 8 to 22 carbon atoms; R 1 , R 2 , R 3 , and R 4 are each independently H or acyl of 1 to 6 carbon atoms; and the pharmaceutically acceptable salts thereof.
Claim 2
Dependent Claim 54 words
A compund in substantially pure form of formula 1: ##STR7## where R is H, OH, or saturated acyloxy of 8 to 22 carbon atoms; R 1 , R 2 , R 3 , and R 4 are each independently H or acyl of 1 to 6 carbon atoms; and the pharmaceutically acceptable salts thereof.
Claim 3
Dependent Claim 21 words
The compound of claim 1 wherein R 1 , R 2 , R 3 , and R 4 are each H.
Claim 4
Dependent Claim 9 words
The compound of claim 2 wherein R is H.
Claim 5
Dependent Claim 16 words
The compound of claim 2 wherein R is saturated acyloxy of 8 to 22 carbon atoms.
Claim 6
Dependent Claim 10 words
The compound of claim 4 wherein R is saturated tetradecanoyl.
Claim 7
Dependent Claim 9 words
The compound of claim 4 wherein R is 13-methyltetradecanoyl.
Claim 8
Dependent Claim 21 words
The compound of claim 1 wherein R 1 , R 2 , R 3 , and R 4 are each acetyl.
Claim 9
Dependent Claim 9 words
The compound of claim 7 wherein R is tetradecanoyl.
Claim 10
Dependent Claim 9 words
The compound of claim 7 wherein R is 13-methyltetradecanoyl.
Claim 11
Independent Claim 101 words
A method for treating helminthiasis which method comprises administering to a subject in need thereof an effective amount of a compound in substantially pure form of formula 1: ##STR8## wherein R is H, OH, or saturated acyloxy of 8 to 22 carbon atoms; R 1 , R 2 , R 3 , and R 4 are each independently H or acyl of 1 to 6 carbon atoms; and the pharmaceuticlaly acceptable salts thereof or an effective amount of a phramaceutical composition wherein the active ingredient is a substantially pure form of the compound of formula 1 or its pharmaceutically acceptable salts.
Claim 12
Independent Claim 101 words
A method for treating helminthiasis which method comprises administering to a subject in need thereof an effective amount of a compound in substantially pure form of formula 1: ##STR8## wherein R is H, OH, or saturated acyloxy of 8 to 22 carbon atoms; R 1 , R 2 , R 3 , and R 4 are each independently H or acyl of 1 to 6 carbon atoms; and the pharmaceuticlaly acceptable salts thereof or an effective amount of a phramaceutical composition wherein the active ingredient is a substantially pure form of the compound of formula 1 or its pharmaceutically acceptable salts.
Claim 13
Dependent Claim 27 words
The method of claim 10 wherein R 1 , R 2 , R 3 , and R 4 are each H; and R is tetradecanoyl or 13-methyltetradecanoyl.
Claim 14
Dependent Claim 70 words
A composition for treating helminthiasis, which comprises a pharmaceutically acceptable excipient and an effective amount of a compound in substantially pure form of formula 1: ##STR9## where R is H, OH, or saturated acyloxy of 8 to 22 carbon atoms; R 1 , R 2 , R 3 , and R 4 are each independently H or acyl of 1 to 6 carbon atoms; and the pharmaceutically acceptable salts thereof.
Claim 15
Dependent Claim 70 words
A composition for treating helminthiasis, which comprises a pharmaceutically acceptable excipient and an effective amount of a compound in substantially pure form of formula 1: ##STR9## where R is H, OH, or saturated acyloxy of 8 to 22 carbon atoms; R 1 , R 2 , R 3 , and R 4 are each independently H or acyl of 1 to 6 carbon atoms; and the pharmaceutically acceptable salts thereof.
Claim 16
Dependent Claim 21 words
The composition of claim 12 wherein R 1 , R 2 , R 3 , and R 4 are each H.
Claim 17
Dependent Claim 9 words
The composition of claim 13 wherein R is H.
Claim 18
Dependent Claim 15 words
The composition of claim 13 wherein R is acyloxy of 8 to 22 carbon atoms.
Claim 19
Dependent Claim 9 words
The composition of claim 15 wherein R is tetradecanoyl.
Claim 20
Dependent Claim 9 words
The composition of claim 15 wherein R is 13-methyltetradecanoyl.
Claim 21
Dependent Claim 21 words
The composition of claim 12 wherein R 1 , R 2 , R 3 , and R 4 are each acetyl.
Claim 22
Dependent Claim 9 words
The composition of claim 18 wherein R is tetradecanoyl.
Claim 23
Dependent Claim 9 words
The composition of claim 18 wherein R is 13-methyltetradecanoyl.

References Cited (Backward Citations)

US3438943A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1991-11-15 1992-05-16 1992-11-15 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1995-11-15 1996-05-16 1996-11-15 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1999-11-15 2000-05-16 2000-11-15 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag